Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
PF-06463922 is a potent and selective next-generation ROS... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
PF-06463922 is a potent and selective next-generation ROS1/ALK inhibitor capable of blocking crizotinib-resistant ROS1 mutations
0
Authors
Helen Zou
22 more
Helen Zou
•
Sergei Timofeevski
20 more
•
Valeria Fantin
Published
March 2, 2015
Paper
Conversation
0
Reviews
0
Bounties
0
Loading PDF viewer…
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Proceedings of the National Academy of Sciences
Topics
Biology
Cancer Oncology
Medicine
Internal Medicine
Pulmonary And Respiratory Medicine
Show all topics
DOI
10.1073/pnas.1420785112
Other Formats
PDF
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Proceedings of the National Academy of Sciences
Topics
Biology
Cancer Oncology
Medicine
Internal Medicine
Pulmonary And Respiratory Medicine
Show all topics
DOI
10.1073/pnas.1420785112
Other Formats
PDF
